Related Experiment Video
Updated: Jan 4, 2026

A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System
Published on: August 30, 2019
Gut microbiome and cancer immunotherapy
Jin-Yu Sun1, Tai-Lang Yin2, Jianhua Zhou3
1Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Sparkfire Scientific Research Group, Nanjing Medical University, Nanjing, China.
The gut microbiome significantly impacts cancer immunotherapy effectiveness and side effects. Modulating gut bacteria can improve patient responses to immune checkpoint inhibitors (ICIs) and reduce toxicity.
Area of Science:
- Microbiology
- Immunology
- Oncology
Background:
- The gut microbiome plays a crucial role in host immune modulation.
- Next-generation sequencing has revealed the microbiome's importance in health and disease.
- Immune checkpoint inhibitors (ICIs) are a major advancement in cancer immunotherapy.
Purpose of the Study:
- To review the relationship between gut microbiome and cancer immunotherapy.
- To elucidate the impact of gut microbiome on ICI efficacy and toxicity.
- To explore methods for manipulating the gut microbiome to enhance cancer immunotherapy.
Main Methods:
- Literature review of studies on gut microbiome and cancer immunotherapy.
- Analysis of research on microbiome-mediated effects on ICI response.
- Synthesis of findings on microbiome modulation strategies.
Main Results:
- Gut microbiome composition influences patient response to ICIs.
- Microbiome modulation can enhance ICI efficacy and mitigate treatment-related adverse events.
- Specific microbial interventions show potential in regulating ICI outcomes.
Conclusions:
- The gut microbiome is a critical factor in cancer immunotherapy success.
- Targeting the gut microbiome offers a promising strategy to optimize ICI therapy.
- Further research is needed to overcome challenges and refine microbiome-based interventions for cancer treatment.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
The Tumor Microenvironment
Psychoneuroimmunology: Diabetes and Cancer
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against...

